APA (7th ed.) Citation

Lisni, I., Lestari, K., & Andalusia, L. R. (2025). Polypharmacy in Type 2 Diabetes Patients of the PROLANIS Program in Indonesia: Identification of Potential Drug-Drug Interaction. Jordan Journal of Pharmaceutical Sciences, 18(1), 245. https://doi.org/10.35516/jjps.v18i1.2783

Chicago Style (17th ed.) Citation

Lisni, Ida, Keri Lestari, and Lucia Rizka Andalusia. "Polypharmacy in Type 2 Diabetes Patients of the PROLANIS Program in Indonesia: Identification of Potential Drug-Drug Interaction." Jordan Journal of Pharmaceutical Sciences 18, no. 1 (2025): 245. https://doi.org/10.35516/jjps.v18i1.2783.

MLA (9th ed.) Citation

Lisni, Ida, et al. "Polypharmacy in Type 2 Diabetes Patients of the PROLANIS Program in Indonesia: Identification of Potential Drug-Drug Interaction." Jordan Journal of Pharmaceutical Sciences, vol. 18, no. 1, 2025, p. 245, https://doi.org/10.35516/jjps.v18i1.2783.